Systemic therapy options for unresectable and metastatic chordomas

Research output: Contribution to journalArticlepeer-review


Chordoma is an exceedingly rare tumor, marked by a slow growth rate. Surgery is the treatment of choice, but the most frequent sites of origin (spine and skull base) make treatment of primary disease challenging. Local relapses affect more than 50% of cases, with a minority of patients being cured by further surgery. Furthermore, metastases occur in at least 20% of patients. For residual or recurrent disease, high-dose radiation therapy may be indicated. Radiation therapy is currently the preferred local treatment when surgery is problematic, exploiting most recent techniques, including proton beams and carbon ions. However, systemic therapy is needed in patients non-amenable to surgery and/or radiation therapy. We reviewed systemic treatments currently available, and targets possibly druggable in the future in this orphan disease.

Original languageEnglish
Pages (from-to)323-330
Number of pages8
JournalCurrent Oncology Reports
Issue number4
Publication statusPublished - Aug 2011


  • Bone sarcoma
  • Chemotherapy
  • Chordoma
  • Sarcomas
  • Systemic therapy options for unresectable and metastatic chordomas
  • Targeted therapy

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Systemic therapy options for unresectable and metastatic chordomas'. Together they form a unique fingerprint.

Cite this